COMBIVIR for Maternal exposure timing unspecified: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 12 adverse event reports in the FDA FAERS database where COMBIVIR was used for Maternal exposure timing unspecified.
Most Reported Side Effects for COMBIVIR
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Foetal exposure during pregnancy | 24 | 22.2% | 4 | 6 |
| Exposure during pregnancy | 17 | 15.7% | 0 | 3 |
| Abortion spontaneous | 12 | 11.1% | 1 | 0 |
| Anaemia | 7 | 6.5% | 0 | 5 |
| Stillbirth | 7 | 6.5% | 1 | 0 |
| Lipodystrophy acquired | 6 | 5.6% | 0 | 0 |
| Abortion induced | 5 | 4.6% | 2 | 0 |
| Diarrhoea | 5 | 4.6% | 0 | 1 |
| Rash | 5 | 4.6% | 0 | 3 |
Other Indications for COMBIVIR
Other Drugs Used for Maternal exposure timing unspecified
VALPROATE (1,477)
ADALIMUMAB (1,280)
NATALIZUMAB (492)
RITONAVIR (486)
EMTRICITABINE\TENOFOVIR DISOPROXIL (333)
LOPINAVIR\RITONAVIR (278)
DIVALPROEX (254)
INTERFERON BETA-1A (245)
DIMETHYL (212)
ATAZANAVIR (169)